Caroline E. Porter

495 total citations
13 papers, 375 citations indexed

About

Caroline E. Porter is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Caroline E. Porter has authored 13 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Caroline E. Porter's work include CAR-T cell therapy research (13 papers), Virus-based gene therapy research (10 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Caroline E. Porter is often cited by papers focused on CAR-T cell therapy research (13 papers), Virus-based gene therapy research (10 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). Caroline E. Porter collaborates with scholars based in United States and Japan. Caroline E. Porter's co-authors include Masataka Suzuki, Amanda Rosewell Shaw, Malcolm K. Brenner, Stephen Gottschalk, Andrew G. Sikora, Kiyonori Tanoue, Norihiro Watanabe, Vlad C. Sandulache, Patricia Castro and Michael Ittman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Science Advances.

In The Last Decade

Caroline E. Porter

12 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caroline E. Porter United States	6	340	236	145	92	65	13	375
Andrea Brennan United States	6	356 1.0×	195 0.8×	249 1.7×	202 2.2×	93 1.4×	10	549
Gray Kueberuwa United Kingdom	10	305 0.9×	138 0.6×	133 0.9×	153 1.7×	95 1.5×	22	397
Joanne A. Hammill Canada	10	387 1.1×	109 0.5×	117 0.8×	254 2.8×	105 1.6×	18	493
Brook Jeang United States	5	505 1.5×	201 0.9×	158 1.1×	175 1.9×	192 3.0×	9	593
Thomas Schaser Germany	10	275 0.8×	206 0.9×	228 1.6×	71 0.8×	90 1.4×	15	412
Daniela Tantalo Australia	6	264 0.8×	84 0.4×	82 0.6×	133 1.4×	74 1.1×	11	304
Lin Fang China	13	162 0.5×	116 0.5×	150 1.0×	98 1.1×	30 0.5×	22	312
Suvi Sorsa Finland	13	623 1.8×	486 2.1×	239 1.6×	220 2.4×	47 0.7×	22	725
Leila Mekkaoui United Kingdom	5	294 0.9×	127 0.5×	147 1.0×	85 0.9×	118 1.8×	8	366
Linfang Li China	12	116 0.3×	159 0.7×	218 1.5×	49 0.5×	22 0.3×	22	382

Countries citing papers authored by Caroline E. Porter

Since Specialization

Citations

This map shows the geographic impact of Caroline E. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline E. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline E. Porter more than expected).

Fields of papers citing papers by Caroline E. Porter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline E. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline E. Porter. The network helps show where Caroline E. Porter may publish in the future.

Co-authorship network of co-authors of Caroline E. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline E. Porter. A scholar is included among the top collaborators of Caroline E. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline E. Porter. Caroline E. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Makawita, Shalini, Caroline E. Porter, Amanda Rosewell Shaw, et al.. (2024). Binary oncolytic adenovirus in combination with HER2-specific autologous CAR VST for treatment of advanced HER2-positive solid tumors (VISTA).. Journal of Clinical Oncology. 42(16_suppl). TPS2679–TPS2679. 6 indexed citations

2.

Morita, Daisuke, Amanda Rosewell Shaw, Greyson Biegert, et al.. (2024). Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity. Journal for ImmunoTherapy of Cancer. 12(12). e009741–e009741. 1 indexed citations

3.

Liao, Kershena S., Hsuan‐Chen Liu, Chieko Michikawa, et al.. (2024). Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors. ImmunoHorizons. 8(8). 598–605. 3 indexed citations

4.

Shaw, Amanda Rosewell, Daisuke Morita, Caroline E. Porter, et al.. (2024). IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer. PubMed. 32(4). 200899–200899.

5.

Chen, Natalie, Daniel Wang, Caroline E. Porter, et al.. (2023). Abstract P3-06-04: Treatment of Metastatic Breast Cancer with Multipotent Oncolytic/Helper Adenovirus CAdVEC. Cancer Research. 83(5_Supplement). P3–6. 2 indexed citations

6.

Wang, Daniel, Caroline E. Porter, Bora Lim, et al.. (2023). Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies. Science Advances. 9(13). eade6790–eade6790. 19 indexed citations

7.

Shaw, Amanda Rosewell, et al.. (2022). HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy. Cancers. 14(11). 2769–2769. 11 indexed citations

8.

Shaw, Amanda Rosewell, Caroline E. Porter, Mary K. McKenna, et al.. (2021). Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors. Communications Biology. 4(1). 368–368. 34 indexed citations

9.

Porter, Caroline E., Amanda Rosewell Shaw, Patricia Castro, et al.. (2020). Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors. Molecular Therapy. 28(5). 1251–1262. 114 indexed citations

10.

Liu, Hsuan‐Chen, Caroline E. Porter, Kershena S. Liao, et al.. (2019). Abstract 574: Overexpression of HER2 in head and neck cancer represents a potential target for T cell immunotherapy. Immunology. 574–574. 1 indexed citations

11.

Liu, Hsuan‐Chen, Caroline E. Porter, Kershena S. Liao, et al.. (2019). Abstract 574: Overexpression of HER2 in head and neck cancer represents a potential target for T cell immunotherapy. Cancer Research. 79(13_Supplement). 574–574. 5 indexed citations

12.

Shaw, Amanda Rosewell, Caroline E. Porter, Norihiro Watanabe, et al.. (2017). Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer. Molecular Therapy. 25(11). 2440–2451. 178 indexed citations

13.

Shaw, Amanda Rosewell, Kiyonori Tanoue, Norihiro Watanabe, et al.. (2016). 513. Armed-Ad Gene Therapy Expressing PD-L1 Minibody Enhances the Anti-Tumor Effect of Adoptively Transferred Chimeric Antigen Receptor T-Cells for Solid Tumor Treatment. Molecular Therapy. 24. S204–S205. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact